Behavioral Economics and Intervention Science

行为经济学和干预科学

基本信息

项目摘要

PROJECT SUMMARY CORE B: Behavioral Economics and Intervention Science (BEIS) Core The Vermont Center on Behavior and Health (VCBH) is dedicated to researching relationships between personal behavior patterns and risk for chronic disease and premature death. The overarching purpose of the Behavioral Economics and Intervention Sciences (BEIS) Core is to provide VCBH investigators with scientific and technical expertise and research infrastructure in three key areas. First, our Core's Decision-Making Module provides expertise in the study of behavioral choice and decision making, with an emphasis on investigating the core cognitive processes (e.g., executive functions) and biases in decision making that may increase vulnerability to risky health behaviors and undermine response to interventions. Toward this end, we have established the BEIS Core Assessment Service, wherein a highly-trained, mobile assessment team administers a comprehensive battery evaluating multiple domains of executive function and biased decision making that includes measures of attention, working memory, inhibition, error monitoring, and sensitivity to incentives, and temporal, probability, and social discounting of rewards. We customize assessment batteries so that they are tailored to the specific aims and population under investigation in individual studies, while also looking to facilitate and support thematically related research in behavioral economics across studies. Second, the BEIS Intervention Sciences Module provides unique expertise in the design and implementation of incentive-based and other behavioral and pharmacological interventions to promote health-related behavior change. We assist investigators in developing and tailoring interventions to the unique characteristics of the population and targeted risk behavior. We also have center expertise in the integration of technology with these interventions to increase their accessibility, while also potentially lowering treatment costs. Finally, our Core's Economic Modeling Module provides assistance with econometric analyses of interventions and health outcomes, including help with the preparation for and conduct of cost-effectiveness, cost-utility and cost-benefit analyses. This includes assistance in calculating the cost-offset associated with treatment outcomes (e.g., cost per life year gained, cost per quality-adjusted life years gained, net savings per dollar invested, and dollars saved per hospitalization case prevented). Taken together, the BEIS Core and its dedicated service modules will continue to provide the expertise and access to the assessments, interventions and technology, and economic modeling central to the research proposed within the VCBH and also across the UVM campus.
项目总结 核心B:行为经济学和干预学(BEIS)核心 佛蒙特州行为与健康中心(VCBH)致力于研究 个人行为模式和慢性病和过早死亡的风险。最重要的目的是 行为经济学和干预科学(BEIS)的核心是为VCBH研究人员提供科学的 以及三个关键领域的技术专长和研究基础设施。第一,我们核心的决策 模块提供行为选择和决策研究方面的专业知识,重点是 研究核心认知过程(例如,执行功能)和决策中的偏差,这可能 增加对危险健康行为的脆弱性,破坏对干预措施的反应。为此,我们 建立了BEIS核心评估服务,其中有一支训练有素的流动评估团队 管理一个全面的小组,评估执行职能和有偏见的决策的多个领域 这包括注意力、工作记忆、抑制、错误监控和对 激励,以及奖励的时间、概率和社会折扣。我们定制评估电池 以便为个别研究中的特定目标和被调查人群量身定做,同时还 希望促进和支持跨研究的行为经济学中主题相关的研究。第二, BEIS干预科学模块提供设计和实施方面的独特专业知识 基于激励和其他行为和药物干预,以促进与健康有关的行为 变化。我们协助调查人员开发和量身定制干预措施,以满足 人口和有针对性的危险行为。我们还拥有中心专业知识,将技术与 这些干预措施旨在增加其可及性,同时也有可能降低治疗成本。最后,我们的 CORE的经济建模模块提供干预措施和健康的计量经济分析 成果,包括帮助筹备和实施成本效益、成本效益和成本效益 分析。这包括帮助计算与治疗结果相关联的成本抵销(例如, 每一寿命年的成本、每质量调整的寿命年的成本、每一美元投资的净节省和美元 防止的每个住院病例节省的费用)。总而言之,BEIS核心及其专用服务模块 将继续提供专业知识和获得评估、干预和技术,以及 VCBH内部和整个UVM园区内提出的研究的核心经济模型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STACEY C SIGMON其他文献

STACEY C SIGMON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STACEY C SIGMON', 18)}}的其他基金

CORE B: Behavioral Economics and Intervention Science (BEIS) Core
核心 B:行为经济学和干预科学 (BEIS) 核心
  • 批准号:
    10626475
  • 财政年份:
    2023
  • 资助金额:
    $ 28.72万
  • 项目类别:
Interim Buprenorphine Treatment to bridge waitlist delays: Stage II evaluation
临时丁丙诺啡治疗以弥补等候名单延误:第二阶段评估
  • 批准号:
    9547358
  • 财政年份:
    2017
  • 资助金额:
    $ 28.72万
  • 项目类别:
Interim Buprenorphine Treatment to bridge waitlist delays: Stage II evaluation
临时丁丙诺啡治疗以弥补等候名单延误:第二阶段评估
  • 批准号:
    9216519
  • 财政年份:
    2017
  • 资助金额:
    $ 28.72万
  • 项目类别:
Interim Buprenorphine Treatment to bridge waitlist delays: Stage II evaluation
临时丁丙诺啡治疗以弥补等候名单延误:第二阶段评估
  • 批准号:
    9985772
  • 财政年份:
    2017
  • 资助金额:
    $ 28.72万
  • 项目类别:
Interim Treatment: Leveraging buprenophine + technology to bridge waitlist delays
临时治疗:利用丁丙诺啡技术来弥补等候名单的延误
  • 批准号:
    8825482
  • 财政年份:
    2014
  • 资助金额:
    $ 28.72万
  • 项目类别:
Behavioral Economics and Intervention Science
行为经济学和干预科学
  • 批准号:
    10015301
  • 财政年份:
    2013
  • 资助金额:
    $ 28.72万
  • 项目类别:
Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Abusers
弱势群体中的低尼古丁含量香烟:阿片类药物滥用者
  • 批准号:
    10477407
  • 财政年份:
    2013
  • 资助金额:
    $ 28.72万
  • 项目类别:
Behavioral Economics and Intervention Science
行为经济学和干预科学
  • 批准号:
    10247648
  • 财政年份:
    2013
  • 资助金额:
    $ 28.72万
  • 项目类别:
Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Abusers
弱势群体中的低尼古丁含量香烟:阿片类药物滥用者
  • 批准号:
    10247027
  • 财政年份:
    2013
  • 资助金额:
    $ 28.72万
  • 项目类别:
Individual differences in stimulant reinforcement as a function of DRD2 allele
作为 DRD2 等位基因功能的刺激强化的个体差异
  • 批准号:
    7932770
  • 财政年份:
    2009
  • 资助金额:
    $ 28.72万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 28.72万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 28.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 28.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 28.72万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 28.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 28.72万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 28.72万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 28.72万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 28.72万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 28.72万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了